Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.825
+0.067 (8.77%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $13.94 million as of December 20, 2024. Its market cap has decreased by -76.68% in one year.
Market Cap
13.94M
Enterprise Value
8.17M
1-Year Change
-76.68%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $13.94M, a decrease of -75.66%. That is a compound annual growth rate of -33.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 13.94M | -73.57% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TherapeuticsMD | 12.69M |
| STRATA Skin Sciences | 12.51M |
| AIM ImmunoTech | 12.50M |
| Kazia Therapeutics | 12.41M |
| Sol-Gel Technologies | 12.28M |
| Imunon | 12.04M |
| Applied DNA Sciences | 11.76M |
| Immuron | 11.76M |